Avita Medical | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Celltrion KRW 18.38B 907.05M 2024-09
Clinuvel Pharmaceuticals 2.43M 414.48K 2024-06
Cochlear AUD 4.9M 600K 2024-06
CSL USD 222M 20M 2024-06
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ecofibre AUD 761K 773K 2024-06
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Mayne Pharma AUD 1.2M 50K 2024-06
Medical Developments International AUD 21K 23K 2024-06
Nanosonics AUD 313K 73K 2024-06
Neuren Pharmaceuticals 0 0 2024-06
Opthea USD 9.88M 619.28K 2024-06
Paradigm Biopharmaceuticals AUD 4K 2.48K 2024-06
Polynovo AUD 178K 131K 2024-06
PYC Therapeutics AUD 6K 30.66K 2024-06
Qiagen NV USD 11.14M 337K 2024-12
Ramsay Health Care AUD 306.4M 7.2M 2024-06
ResMed USD 775K 886K 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Telix Pharmaceuticals AUD 470K 42K 2024-06
Tilray USD 7.77M 2.08M 2024-11
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Avita Medical Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.